TH81969A - Pharmaceutical mixtures - Google Patents
Pharmaceutical mixturesInfo
- Publication number
- TH81969A TH81969A TH601001772A TH0601001772A TH81969A TH 81969 A TH81969 A TH 81969A TH 601001772 A TH601001772 A TH 601001772A TH 0601001772 A TH0601001772 A TH 0601001772A TH 81969 A TH81969 A TH 81969A
- Authority
- TH
- Thailand
- Prior art keywords
- substance
- pharmaceutical mixtures
- salts
- characteristic
- pharmaceutical formulation
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 5
- 150000003839 salts Chemical class 0.000 claims abstract 3
- 239000011780 sodium chloride Substances 0.000 claims abstract 3
- 239000000126 substance Substances 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N furane Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract 2
- DRYRBWIFRVMRPV-UHFFFAOYSA-N quinazolin-4-amine Chemical class C1=CC=C2C(N)=NC=NC2=C1 DRYRBWIFRVMRPV-UHFFFAOYSA-N 0.000 abstract 2
- 230000001594 aberrant Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Abstract
DC60 (17/07/49) สารผสมตามสูตรเชิงเภสัชกรรมที่ให้ทางปาก ที่ประกอบด้วยเกลือไดทอไซเลต ของ 4-ควิแนซอลินแอมีน ได้ถูกอธิบายไว้รวมทั้งวิธีการใช้สารนี้ในการรักษาความผิดปรกติ ที่กำหนดลักษณะ โดยกิจกรรมวิปลาส (aberrant) ของ erbB แฟมิลี PTK สารผสมตามสูตรเชิงเภสัชกรรมที่ให้ทางปาก ที่ประกอบด้วยเกลือไอทอไซเลต ของ 4-ควิแนซอลินแอมีน ได้ถูกอธิบายไว้รวมทั้งวิธีการ ใช้สารนี้ในการรักษาความผิดปรกติ ที่กำหนดลักษณะ โดยกิจกรรมวิปลาส (aberant) ของ erbB แฟมิลี PTK สิทธิบัตรยา DC60 (17/07/49) Pharmaceutical formulation mixtures administered orally. Containing dithoxylate salts of 4-quinazolin amine Have been described, including how this substance is used to treat the disorder. Characteristic By aberrant activity of the erbB Family PTK, the oral pharmaceutical formulation mixtures were Containing ioxylate salts of 4-quinazolin amine Has been described, including how Use this substance to treat anomalies. Characteristic By the aberant activity of erbB Family PTK patent drug
Claims (2)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH81969B TH81969B (en) | 2006-12-21 |
| TH81969A true TH81969A (en) | 2006-12-21 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2485131C2 (en) | Pyridine derivatives substituted by heterocyclic ring and phosphonomethyl group, and antimycotic agent containing them | |
| RU2394031C2 (en) | Quaternary ammonium salts as m3 antagonists | |
| HRP20150119T1 (en) | N-substituted glycine derivatives: hydroxylase inhibitors | |
| ME01312B (en) | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors | |
| RU2006130000A (en) | ORGANIC COMPOUNDS | |
| CA2445333A1 (en) | Quinoline derivatives and quinazoline derivatives having azolyl group | |
| FR2903107B1 (en) | IMIDAZOPYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE | |
| JP2010530431A5 (en) | ||
| ATE307810T1 (en) | IMIDAZOLE-2-CARBONIC ACID AMIDE DERIVATIVES AS RAF-KINASE INHIBITORS | |
| UA109421C2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING SIGMA-RECEPTOR LIGANDS | |
| RU2020119562A (en) | QUINAZOLINE COMPOUND AND ITS APPLICATION | |
| SE0301701D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| RU2009102270A (en) | THIAZOLYL UREA DERIVATIVES AS PHOSPHATIDYLINOSYTOL-3-KINASE INHIBITORS | |
| WO2006051314A3 (en) | Guanidine derivatives as inhibitors of ddah | |
| HRP20120344T1 (en) | N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression. | |
| SE0301699D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| SE0002476D0 (en) | New compounds | |
| PT1412332E (en) | QUINOLINE DERIVATIVES AND ITS USE AS ANTITUMOR AGENTS | |
| HRP20050831A2 (en) | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents | |
| TH81969A (en) | Pharmaceutical mixtures | |
| DK1634595T3 (en) | N-Phenylbenzamide derivatives as drugs for the treatment of chronic obstructive pulmonary disease (COPD) | |
| TH81969B (en) | Pharmaceutical mixtures | |
| HRP20130983T1 (en) | Arylcyclopropylacetamide derivatives useful as glucokinase activators | |
| RU2446158C9 (en) | Substituted isoindoles as bace inhibitors and use thereof | |
| TH84863A (en) | Compounds, mixtures containing these substances, preparations of these substances And the use of these substances |